Venetoclax plus azacitidine in younger adults with acute myeloid leukemia beyond historical comparisons. Comment on: "Venetoclax and azacitidine for younger acute myeloid leukemia patients independent of fitness for intensive chemotherapy"
Year: 2026
Type: article
Abstract: Not available.
Source: Haematologica
Authors: Xia Jiang, Ying Lu
Institutions: Ningbo University Affiliated Hospital, Ningbo University
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,157
OpenAlex ID: W7221862947
FWCI:
Cites:
Cited by:
Related to: